Incidental versus clinically diagnosed differentiated thyroid cancer in both adult and elderly subjects: histological characteristics and follow-up in a retrospective analysis from a single institution.


Journal

Endocrine
ISSN: 1559-0100
Titre abrégé: Endocrine
Pays: United States
ID NLM: 9434444

Informations de publication

Date de publication:
06 2020
Historique:
received: 16 09 2019
accepted: 13 01 2020
pubmed: 24 1 2020
medline: 22 6 2021
entrez: 24 1 2020
Statut: ppublish

Résumé

Most thyroid cancer are incidentally diagnosed. However, little is known on the different modalities of incidental diagnosis in adult versus older patients. We retrospectively analyzed data from 440 patients consecutively diagnosed with differentiated thyroid cancer (DTC) in a single institution. Modalities of diagnosis were categorized as follows: (A) clinically diagnosed, nonincidental cases; (B) incidental during carotid power-duplex (CPD); (C) incidental during neck imaging other than carotid power-duplex; (D) incidental during imaging workup of thyroid dysfunction or at histological examination after thyroidectomy for benign lesions. Demographics, histology and follow-up were compared between adult (<65 years) and older (≥65 years) patients according to the different modalities of diagnosis. A total of 363 and 67 cases were recorded in adult and older patients, respectively with incidental proportions of 79% and 85%, respectively. A P < 0.001 significant difference in the modality of diagnosis was found between adult and older subjects, the latter presenting with a higher prevalence of Group B. In the nonincidental group, papillary histotype, larger size, and extrathyroidal invasion were more frequently observed in older subjects. Disease-free survival was comparable between adult and older subjects in the incidental cases, whereas it was reduced, though not significantly, in older subjects. Incidental cases of DTC are more frequently diagnosed in the old subjects and are mainly due to CPD. Disease-free survival is comparable between adult and older subjects in both incidental and nonincidental cases, although it may be slightly reduced in nonincidentally diagnosed older patients.

Identifiants

pubmed: 31970586
doi: 10.1007/s12020-020-02200-z
pii: 10.1007/s12020-020-02200-z
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

584-591

Références

J.R. Burgess, P. Tucker, Incidence trends for papillary thyroid carcinoma and their correlation with thyroid surgery and thyroid fine needle aspirate cytology. Thyroid 16, 47–53 (2006)
doi: 10.1089/thy.2006.16.47
M. Colonna, A.V. Guizard, C. Schvartz, M. Velten, N. Raverdy, F. Molinie, P. Delafosse, B. Franc, P. Grosclaude, A time trend analysis of papillary and follicular cancers as a function of tumour size: a study of data from six cancer registries in France (1983–2000). Eur. J. Cancer 43, 891–900 (2007)
doi: 10.1016/j.ejca.2006.11.024
L. Leenhardt, P. Grosclaude, L. Cherie-Challine; Thyroid Cancer Committee, Increased incidence of thyroid carcinoma in France: a true epidemic or thyroid nodule management effects? Report from the French Thyroid Cancer Committee. Thyroid 14, 1056–1060 (2004)
doi: 10.1089/thy.2004.14.1056
S. Liu, R. Semenciw, A.M. Ugnat, Y. Mao, Increasing thyroid cancer incidence in Canada, 1970–1996: time trends and age-period-cohort effects. Br. J. Cancer 85, 1335–1339 (2001)
doi: 10.1054/bjoc.2001.2061
R.M. Reynolds, J. Weir, D.L. Stockton, D.H. Brewster, T.C. Sandeep, M.W. Strachan, Changing trends in incidence and mortality of thyroid cancer in Scotland. Clin. Endocrinol. 62, 156–162 (2005)
doi: 10.1111/j.1365-2265.2004.02187.x
G. Smailyte, E. Miseikyte-Kaubriene, J. Kurtinaitis, Increasing thyroid cancer incidence in Lithuania in 1978–2003. BMC Cancer 6, 284 (2006)
doi: 10.1186/1471-2407-6-284
G. Ceresini, L. Corcione, M. Michiara, P. Sgargi, G. Teresi, A. Gilli, E. Usberti, E. Silini, G.P. Ceda, Thyroid cancer incidence by histological type and related variants in a mildly iodine-deficient area of Northern Italy, 1998 to 2009. Cancer 118, 5473–5480 (2012)
doi: 10.1002/cncr.27591
L. Rahib, B.D. Smith, R. Aizenberg, A.B. Rosenzweig, J.M. Fleshman, L.M. Matrisian, Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 74, 2913–2921 (2014)
doi: 10.1158/0008-5472.CAN-14-0155
L. Davies, H.G. Welch, Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA 295, 2164–2167 (2006)
doi: 10.1001/jama.295.18.2164
L. Leenhardt, M.O. Bernier, M.H. Boin-Pineau, B. Conte Devolx, R. Maréchaud, P. Niccoli-Sire, M. Nocaudie, J. Orgiazzi, M. Schlumberger, J.L. Wémeau, L. Chérie-Challine, F. De Vathaire, Advances in diagnostic practices affect thyroid cancer incidence in France. Eur. J. Endocrinol. 150, 133–139 (2004)
doi: 10.1530/eje.0.1500133
P.L. Horn-Ross, D.Y. Lichtensztajn, C.A. Clarke, C. Dosiou, I. Oakley-Girvan, P. Reynolds, S.L. Gomez, D.O. Nelson, Continued rapid increase in thyroid cancer incidence in California: trends by patient, tumor, and neighborhood characteristics. Cancer Epidemiol. Biomark. Prev. 23, 1067–1079 (2014)
doi: 10.1158/1055-9965.EPI-13-1089
S.R. Baker, W.A. Bhatti, The thyroid cancer epidemic: is it the dark side of the CT revolution? Eur. J. Radiol. 60, 67–69 (2006)
doi: 10.1016/j.ejrad.2006.04.022
N. Mevawalla, T. McMullen, S. Sidhu, M. Sywak, B. Robinson, L. Delbridge, Presentation of clinically solitary thyroid nodules in surgical patients. Thyroid 21, 55–59 (2011)
doi: 10.1089/thy.2009.0230
J.P. Brito, A.A. Nofal, V.M. Montori, I.D. Hay, J.C. Morris, The impact of subclinical disease and mechanism of detection on the rise in thyroid cancer incidence: a population-based study in Olmsted county, Minnesota during 1935 through 2012. Thyroid 9, 999–1007 (2015)
doi: 10.1089/thy.2014.0594
C. La Vecchia, M. Malvezzi, C. Bosetti, W. Garavello, P. Bertuccio, F. Levi, E. Negri, Thyroid cancer mortality and incidence: a global overview. Int. J. Cancer 136, 2187–2195 (2015)
doi: 10.1002/ijc.29251
M. Marina, G.P. Ceda, R. Aldigeri, G. Ceresini, Causes of referral to the first endocrine visit of patients with thyroid carcinoma in a mildly iodine-deficient area. Endocrine 57, 247–255 (2017)
doi: 10.1007/s12020-016-1140-1
K.L. Gupta, Neoplasm of the thyroid gland. Clin. Geriatr. Med. 11, 271–290 (1995)
doi: 10.1016/S0749-0690(18)30297-0
E. Mazzaferri, Management of a solitary thyroid nodule. N. Engl. J. Med. 328, 553–559 (1993)
doi: 10.1056/NEJM199302253280807
M.M. Boltz, C.S. Hollenbeak, E. Schaefer, D. Goldenberg, B.D. Saunders, Attributable costs of differentiated thyroid cancer in the elderly medicare population. Surgery 154, 1363–1369 (2013)
doi: 10.1016/j.surg.2013.06.042
M. Raffaelli, R. Bellantone, P. Princi, C. De Crea, E.D. Rossi, G. Fadda, C.P. Lombardi, Surgical treatment of thyroid diseases in elderly patients. Am. J. Surg. 200, 467–472 (2010)
doi: 10.1016/j.amjsurg.2009.12.020
M.N. Nikiforova, E.T. Kimura, M. Gandhi, P.W. Biddinger, J.A. Knauf, F. Basolo, Z. Zhu, R. Giannini, G. Salvatore, A. Fusco, M. Santoro, J.A. Fagin, Y.E. Nikiforov, BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas. J. Clin. Endocrinol. Metab. 88, 5399–5404 (2003)
doi: 10.1210/jc.2003-030838
L. Fugazzola, E. Puxeddu, N. Avenia, C. Romei, V. Cirello, A. Cavaliere, P. Faviana, D. Mannavola, S. Moretti, S. Rossi, M. Sculli, V. Bottici, P. Beck-Peccoz, F. Pacini, A. Pinchera, F. Santeusanio, R. Elisei, Correlation between BRAF-V600E mutation and clinico-pathologic parameters in papillary thyroid carcinoma: data from a multicentric Italian study and review of the literature. Endocr. Relat. Cancer 13, 455–464 (2006)
doi: 10.1677/erc.1.01086
G.C. Biliotti, F. Martini, V. Vezzosi, P. Seghi, F. Tozzi, A. Castagnoli, G. Basili, A. Peri, Specific features of differentiated thyroid carcinoma in patients over 70 years of age. J. Surg. Oncol. 93, 194–198 (2006)
doi: 10.1002/jso.20512
C.S. Hollenbeak, M.M. Boltz, E.W. Schaefer, B.D. Saunders, D. Goldenberg, Recurrence of differentiated thyroid cancer in the elderly. Eur. J. Endocrinol. 168, 549–556 (2013)
doi: 10.1530/EJE-12-0848
R. Elisei, E. Molinaro, L. Agate, V. Bottici, L. Masserini, C. Ceccarelli, F. Lippi, L. Grasso, F. Basolo, G. Bevilacqua, P. Miccoli, G. Di Coscio, P. Vitti, F. Pacini, A. Pinchera, Are the clinical and pathological features of differentiated thyroid carcinoma really changed over the last 35 years? Study on 4187 patients from a single Italian Institution to answer this question. J. Clin. Endocrinol. Metab. 95, 1516–1527 (2010)
doi: 10.1210/jc.2009-1536
World Health Organisation, Definition of an older or elderly person (WHO, Geneva, 2007). http://www.who.int/healthinfo/survey/ageingdefnolder/en/index.html
C. Hudon, M. Fortin, A. Vanasse, Cumulative illness rating scale was a reliable and valid index in a family practice context. J. Clin. Epidemiol. 58, 603–608 (2005)
doi: 10.1016/j.jclinepi.2004.10.017
M.B. Amin, S. Edge, F. Greene, D.R. Byrd, R.K. Brookland, M.K. Washington, J.E. Gershenwald, C.C. Compton, K.R. Hess, D.C. Sullivan, J.M. Jessup, J.D. Brierley, L.E. Gaspar, R.L. Schilsky, C.M. Balch, D.P. Winchester, E.A. Asare, M. Madera, D.M. Gress, L.R. Meyer. AJCC Cancer Staging Manual. 8th edn. (Springer International Publishing, New York, 2017)
B.R. Haugen, E.K. Alexander, K.C. Bible, G.M. Doherty, S.J. Mandel, Y.E. Nikiforov, F. Pacini, G.W. Randolph, A.M. Sawka, M. Schlumberger, K.G. Schuff, S.I. Sherman, J.A. Sosa, D.L. Steward, R.M. Tuttle, L. Wartofsky, 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 1, 1–133 (2016)
doi: 10.1089/thy.2015.0020
F. Yoo, I. Chaikhoutdinov, R. Mitzner, J. Liao, D. Goldenberg, Characteristics of Incidentally discovered thyroid cancer. JAMA Otolaryngol. Head. Neck. Surg. 139, 1181–1186 (2013)
doi: 10.1001/jamaoto.2013.5050
L. Davies, M. Oulette, M. Hunter, H.G. Welch, The increasing incidence of small thyroid cancers: where are the cases coming from? Laryngoscope 120, 2446–2451 (2010)
doi: 10.1002/lary.21076
L. Lamartina, G. Grani, E. Arvat, A. Nervo, M.C. Zatelli, R. Rossi, E. Puxeddu, S. Morelli, M. Torlontano, M. Massa, R. Bellantone, A. Pontecorvi, T. Montesano, L. Pagano, L. Daniele, L. Fugazzola, G. Ceresini, R. Bruno, R. Rossetto, S. Tumino, M. Centanni, D. Meringolo, M.G. Castagna, D. Salvatore, A. Nicolucci, G. Lucisano, S. Filetti, C. Durante, 8th edition of the AJCC/TNM staging system of thyroid cancer: what to expect (ITCO#2). Endocr. Relat. Cancer 25, L7–L11 (2018)
doi: 10.1530/ERC-17-0453
M.N. Minuto, M. Miccoli, D. Viola, C. Ugolini, R. Giannini, L. Torregrossa, L. Antonangeli, F. Aghini-Lombardi, R. Elisei, F. Basolo, P. Miccoli, Incidental versus clinically evident thyroid cancer: a 5-year follow-up study. Head. Neck 35, 408–412 (2013)
doi: 10.1002/hed.22974
Y.E. Nikiforov, R.R. Seethala, G. Tallini, Z.W. Baloch, F. Basolo, L.D. Thompson, J.A. Barletta, B.M. Wenig, A. Al Ghuzlan, K. Kakudo, T.J. Giordano, V.A. Alves, E. Khanafshar, S.L. Asa, A.K. El-Naggar, W.E. Gooding, S.P. Hodak, R.V. Lloyd, G. Maytal, O. Mete, M.N. Nikiforova, V. Nosé, M. Papotti, D.N. Poller, P.M. Sadow, A.S. Tischler, R.M. Tuttle, K.B. Wall, V.A. LiVolsi, G.W. Randolph, R.A. Ghossein, Nomenclature revision for encapsulated follicular variant of papillary thyroid carcinoma. JAMA Oncol. 2, 1023–1029 (2016)
doi: 10.1001/jamaoncol.2016.0386

Auteurs

Michela Marina (M)

Unit of Internal Medicine and Oncological Endocrinology, Department of Medicine and Surgery, University Hospital of Parma, University of Parma, Parma, Italy.

Maria Francesca Serra (MF)

Unit of Internal Medicine and Oncological Endocrinology, Department of Medicine and Surgery, University Hospital of Parma, University of Parma, Parma, Italy.

Raffaella Aldigeri (R)

Unit of Internal Medicine and Oncological Endocrinology, Department of Medicine and Surgery, University Hospital of Parma, University of Parma, Parma, Italy.

Graziano Ceresini (G)

Unit of Internal Medicine and Oncological Endocrinology, Department of Medicine and Surgery, University Hospital of Parma, University of Parma, Parma, Italy. graziano.ceresini@unipr.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH